Literature DB >> 189312

Rauscher-leukemia-virus-related sequences in human DNA: presence in some tissues of some patients with hemotopoietic neoplasias and absence in DNA from other tissues.

G S Aulakh, R C Gallo.   

Abstract

A [3H[cDNA probe synthesized from the RNA genome of Rauscher murine leukemia virus (MuLVR) and purified by hybridization to MuLVR70S RNA was hybridized to DNA from human normal and hemotopoietic neoplasia tissues. This cDNA hybridized completely to its homologous 70S RNA and was free of self-complementary sequences. Sequences complementary to MuLVR cDNA were found in DNA from tissues of some patients with leukemia (2 of 8), Hodgkin's disease (3 of 10), and one patient with multiple myeloma. DNA from spleen and kidney of a patient with nonneoplastic disease did not contain detectable MuLVR-related sequences. These virus-related sequences in the DNA from these neoplastic tissues were related but not identical to MuLVR sequences because differences of approximately 6 degrees in the midpoints of thermal elution profiles were found between the heterologous and homologous duplexes. These nucleotide sequences are not the same as the proviral sequences of baboon type-C virus previously found from some other patients with leukemia [Reitz et al. (1976) Proc. Natl. Acad. Sci. USA 73,2113-2117; Wong-Staal et al. (1976) Nature 262, 190-195], because there is no sequence homology between nucleic acids from MuLVR and baboon virus. The absence of these nucleic acid sequences in many tissues of patients with neoplasia and from the few tissues examined from people with nonneoplastic disease suggests that they are not endogenous elements but are acquired after fertilization. Taken together with the previous detection of baboon and woolly monkey type-C viral related components in some human tumors, the results suggest acquisition of at least three types of type-C viral sequences in the human population.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 189312      PMCID: PMC393258          DOI: 10.1073/pnas.74.1.353

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  C-type virus antigens detected by immunofluorescence in human bone tumour cultures.

Authors:  C Zurcher; J Brinkhof; P Bentvelzen; J C De Man
Journal:  Nature       Date:  1975-04-03       Impact factor: 49.962

2.  Viral-related information in oncornavirus-lik particles isolated from cultures of marrow cells from leukemic patients in relapse and remission.

Authors:  T W Mak; S Kurtz; J Manaster; D Housman
Journal:  Proc Natl Acad Sci U S A       Date:  1975-02       Impact factor: 11.205

3.  Isolation of infectious C-type oncornavirus from human leukaemic bone marrow cells.

Authors:  K Nooter; A M Aarssen; P Bentvelzen; F G De Groot; F G Van Pelt
Journal:  Nature       Date:  1975-08-14       Impact factor: 49.962

4.  Reverse transcriptase activity of human acute leukaemic cells: purification of the enzyme, response to AMV 70S RNA, and characterization of the DNA product.

Authors:  M G Sarngadharan; P S Sarin; M S Reitz; R C Gallo
Journal:  Nat New Biol       Date:  1972-11-15

5.  Antigen related to mammalian type-C RNA viral p30 proteins is located in renal glomeruli in human systemic lupus erythematosus.

Authors:  R C Mellors; J W Mellors
Journal:  Proc Natl Acad Sci U S A       Date:  1976-01       Impact factor: 11.205

6.  Growth and differentiation in culture of leukemic leukocytes from a patient with acute myelogenous leukemia and re-identification of type-C virus.

Authors:  R E Gallagher; S Z Salahuddin; W T Hall; K B McCredie; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

7.  Search for antigens and antibodies crossreactive with type C viruses of the woolly monkeys and gibbon ape in animal models and in humans.

Authors:  J R Stephenson; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1976-05       Impact factor: 11.205

8.  Proviral sequences of baboon endogenous type C RNA virus in DNA of human leukaemic tissues.

Authors:  F Wong-Staal; D Gillespie; R C Gallo
Journal:  Nature       Date:  1976-07-15       Impact factor: 49.962

9.  Specificities of human immunoglobulins reactive with antigens in preparations of several mammalian type-C viruses.

Authors:  H W Snyder; T Pincus; E Fleissner
Journal:  Virology       Date:  1976-11       Impact factor: 3.616

10.  Natural antibodies in sera from healthy humans to antigens on surfaces of type C RNA viruses and cells from primates.

Authors:  T Aoki; M J Walling; G S Bushar; M Liu; K C Hsu
Journal:  Proc Natl Acad Sci U S A       Date:  1976-07       Impact factor: 11.205

View more
  6 in total

1.  Genomic and phenotypic analyses of Mycoplasma pneumoniae strains.

Authors:  D K Chandler; S Razin; E B Stephens; R Harasawa; M F Barile
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

2.  Nucleic acid relationships among Acholeplasma species.

Authors:  G S Aulakh; E B Stephens; D L Rose; J G Tully; M F Barile
Journal:  J Bacteriol       Date:  1983-03       Impact factor: 3.490

3.  Retrovirus sequences in a leukemic gibbon and its contact: evidence for partial provirus in the nonleukemic gibbon.

Authors:  F Wong-Staal; M S Reitz; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

4.  Isolation and identification of lymphocytic and myelogenous leukemia-specific sequences in genomes of gibbon oncornaviruses.

Authors:  L Sun; T G Kawakami
Journal:  J Virol       Date:  1980-08       Impact factor: 5.103

Review 5.  Human leukemia viruses? RNA tumor viruses, human malignancies, and concepts of viral carcinogenesis.

Authors:  R Hehlmann; V Erfle
Journal:  Blut       Date:  1980-10

6.  Herpesvirus saimiri-induced lymphoblastoid rabbit cell line: growth characteristics, virus persistence, and oncogenic properties.

Authors:  D V Ablashi; S Schirm; B Fleckenstein; A Faggioni; J Dahlberg; H Rabin; W Loeb; G Armstrong; J W Peng; G Aulahk
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.